
Pete Jackson, PhD

Exploring the Impact of the 21st Century Cures Act

Patient-Reported Outcomes: Design with the End in Mind

Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders

Advancing Models of Patient Engagement: Patient Organizations as Research and Data Partners

Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information

Tackling COVID-19 in Nigeria: Health Tech Rising to the Challenge

Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information

Experts Discuss Long-Term Data Collection for Cell and Gene Therapies

Cures for Life Quarterly

Los Angeles Business Journal Names Milken Institute Research Organization of the Year
